Myricx Bio Announces £90M ($114M) Series a Financing to Advance Its Novel Nmti-ADC Therapeutics Into Clinical Development
Myricx Bio宣佈獲得9000萬英鎊(1.14億美元)的A輪融資,用於推進其新型Nmti-ADC therapeutics進入臨床開發階段。
Myricx Bio Announces £90M ($114M) Series a Financing to Advance Its Novel Nmti-ADC Therapeutics Into Clinical Development
Myricx Bio宣佈獲得9000萬英鎊(1.14億美元)的A輪融資,用於推進其新型Nmti-ADC therapeutics進入臨床開發階段。
譯文內容由第三人軟體翻譯。